Institutional investors purchased a net $23.6 million shares of TEVA during the quarter ended September 2016, and now own 57.20% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 5.5 Million shares of Teva Pharmaceutical
BARROW, HANLEY, MEWHINNEY & STRA... Bought 3.9 Million shares of Teva Pharmaceutical
JPMORGAN SECURITIES LLC Bought 3.6 Million shares of Teva Pharmaceutical